ArticleiScience2026
MolGramTreeNet: A multimodal molecular property prediction model via grammar tree-constrained molecular representation.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molecular property prediction is pivotal for drug discovery. However, existing methods that rely on linear SMILES or 2D graphs often overlook explicit hierarchical structures and chemical grammar constraints. To address this limitation, we propose MolGramTreeNet, a multimodal framework that leverages grammar tree-guided representations. The framework parses SMILES into hierarchical trees using context-free grammar, explicitly encoding chemical rules. The architecture employs a dual-path encoder: a Transformer captures tree-based hierarchical semantics, while a Graph Convolutional Network extracts 2D topological features. These fused features generate comprehensive molecular representations. Experiments conducted across ten datasets demonstrate that MolGramTreeNet outperforms eight baseline models, achieving performance improvements of 2.86%-21.47%. Ablation studies confirm the grammar tree's contribution. This approach significantly enhances both accuracy and interpretability, thereby advancing AI-driven drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.